MapLight Therapeutics, Inc. (MPLT)
9.82
+0.19
(+1.97%)
USD |
NASDAQ |
Oct 02, 16:00
9.94
+0.12
(+1.22%)
After-Hours: 06:56
MapLight Therapeutics Total Assets (Quarterly) : 368.35M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 368.35M |
| March 31, 2026 | 418.79M |
| December 31, 2025 | 479.51M |
| September 30, 2025 | 257.22M |
| Date | Value |
|---|---|
| June 30, 2025 | 84.12M |
| March 31, 2025 | 111.57M |
| June 30, 2024 | |
| March 31, 2024 | 192.57M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 3.189B |
| Cullinan Therapeutics, Inc. | 363.79M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.05M |
| Shareholders Equity (Quarterly) | 348.30M |
| Debt to Equity Ratio | 0.0057 |
| Current Ratio | 16.52 |
| Net Debt Paydown Yield | 0.05% |